Your browser doesn't support javascript.
loading
International haemovigilance: what have we learned and what do we need to do next?
Wood, E M; Ang, A L; Bisht, A; Bolton-Maggs, P H; Bokhorst, A G; Flesland, O; Land, K; Wiersum-Osselton, J C; Schipperus, M R; Tiberghien, P; Whitaker, B I.
Afiliação
  • Wood EM; Transfusion Research Unit, Monash University, Melbourne, Victoria, Australia.
  • Ang AL; Department of Clinical Haematology, Monash Health, Melbourne, Victoria, Australia.
  • Bisht A; Blood Services Group, Health Sciences Authority, Singapore.
  • Bolton-Maggs PH; Department of Haematology, Singapore General Hospital, Singapore.
  • Bokhorst AG; Haemovigilance Programme of India, National Institute of Biologicals, Ministry of Health & Family Welfare, Noida, India.
  • Flesland O; Serious Hazards of Transfusion, Manchester, UK.
  • Land K; University of Manchester, Manchester, UK.
  • Wiersum-Osselton JC; Transfusion and Transplantation Reactions in Patients (TRIP), National Haemovigilance and Biovigilance Office, Leiden, The Netherlands.
  • Schipperus MR; Norwegian Directorate of Health, Oslo, Norway.
  • Tiberghien P; Blood Systems Inc., Tempe, Arizona, USA.
  • Whitaker BI; Department of Pathology, University of Texas Health Science Center, San Antonio, Texas, USA.
Transfus Med ; 29(4): 221-230, 2019 Aug.
Article em En | MEDLINE | ID: mdl-30729612

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doadores de Sangue / Transfusão de Sangue / Segurança do Sangue / Reação Transfusional Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doadores de Sangue / Transfusão de Sangue / Segurança do Sangue / Reação Transfusional Idioma: En Ano de publicação: 2019 Tipo de documento: Article